Molecular Diagnostic company Myriad Genetics has secured a USD 90 million asset-based credit facility, with an option to increase to USD 115 million. The facility was established with JPMorgan Chase Bank as the administrative agent and issuing bank, along with Wells Fargo Bank and Bank of America as lender parties.
The funds are expected to provide the company with additional financial flexibility to support its growth strategy.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.